ESGO Statement on the Role of CA/125 Measurement in Follow-Up of Epithelial Ovarian Cancer

被引：6
|
作者：
van der Zee, Ate G. J. [1 ]
Colombo, Nicoletta [1 ]
Gitsch, Gerald [1 ]
Reed, Nicolas [1 ]
Amant, Frederic [1 ]
Cibula, David [1 ]
Kesic, Vesna I. [1 ]
Kimmig, Rainer [1 ]
Lopes, Alberto D. B. [1 ]
Markowska, Janina [1 ]
Marth, Christian [1 ]
Radolakis, Alexander [1 ]
Salvesen, Helga [1 ]
Vaitkiene, Daiva [1 ]
Verheijen, Rene H. M. [1 ]
Zola, Paolo [1 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2012年 / 22卷 / 01期
关键词：
D O I：
10.1097/IGC.0b013e3182261f15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：175 / 175
页数：1
相关论文
共 50 条
  • [41] The role of CA 125 in screening for ovarian cancer
    Rosenthal, AN
    Jacobs, IJ
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1998, 13 (04): : 216 - 220
  • [42] Follow-up care of ovarian cancer
    Oskay-Oezcelik, G.
    Lichtenegger, W.
    Sehouli, J.
    ONKOLOGE, 2009, 15 (04): : 433 - 439
  • [43] Cancer Antigen 125: Lost to Follow-Up? A European Society of Gynaecological Oncology Consensus Statement
    Verheijen, Rene H. M.
    Cibula, David
    Zola, Paolo
    Reed, Nicolas
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (01) : 170 - 174
  • [44] Prognostic role of CA-125 nadir in stage IV epithelial ovarian cancer
    Prat, Aleix
    Parera, Marta
    Del Campo, Josep Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) : 1771 - 1772
  • [45] Risk of epithelial ovarian cancer among women with benign ovarian tumors: a follow-up study
    Guleria, Sonia
    Jensen, Allan
    Toender, Anita
    Kjaer, Susanne K.
    CANCER CAUSES & CONTROL, 2020, 31 (01) : 25 - 31
  • [46] Risk of epithelial ovarian cancer among women with benign ovarian tumors: a follow-up study
    Sonia Guleria
    Allan Jensen
    Anita Toender
    Susanne K. Kjaer
    Cancer Causes & Control, 2020, 31 : 25 - 31
  • [47] Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE
    Morice, Philippe
    Scambia, Giovanni
    Abu-Rustum, Nadeem R.
    Acien, Maribel
    Arena, Alessandro
    Brucker, Sara
    Cheong, Ying
    Collinet, Pierre
    Fanfani, Francesco
    Filippi, Francesca
    Eriksson, Ane Gerda Zahl
    Gouy, Sebastien
    Harter, Philipp
    Matias-Guiu, Xavier
    Pados, George
    Pakiz, Maja
    Querleu, Denis
    Rodolakis, Alexandros
    Rousset-Jablonski, Christine
    Stepanyan, Artem
    Testa, Antonia Carla
    Macklon, Kirsten Tryde
    Tsolakidis, Dimitrios
    De Vos, Michel
    Planchamp, Francois
    Grynberg, Michael
    LANCET ONCOLOGY, 2024, 25 (11): : e602 - e610
  • [48] Ovarian cancer: the duplicity of CA125 measurement
    Karam, Amer K.
    Karlan, Beth Y.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (06) : 335 - 339
  • [49] Ovarian cancer: the duplicity of CA125 measurement
    Amer K. Karam
    Beth Y. Karlan
    Nature Reviews Clinical Oncology, 2010, 7 : 335 - 339
  • [50] Timing of measurement of Ca 125 in possible ovarian cancer
    Crawford, M.
    Devine, C.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 : 20 - 20
12345